Strengths and weaknesses of pneumococcal conjugate vaccines

Multivalent vaccines addressing an increasing number of Streptococcus pneumoniae types (7-, 10-, 13-, 15-, 20-valent) have been licensed over the last 22 years. The use of polysaccharide-protein conjugate vaccines has been pivotal in reducing the incidence of invasive pneumococcal disease despite th...

Descripción completa

Detalles Bibliográficos
Autores principales: Micoli, Francesca, Romano, Maria Rosaria, Carboni, Filippo, Adamo, Roberto, Berti, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027807/
https://www.ncbi.nlm.nih.gov/pubmed/36652051
http://dx.doi.org/10.1007/s10719-023-10100-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027807/
https://www.ncbi.nlm.nih.gov/pubmed/36652051
http://dx.doi.org/10.1007/s10719-023-10100-3

Ejemplares similares